EXPERIENCE OF USE OF ITOPRIDE FOR THE TREATMENT OF ENT-MANIFESTATIONS OF LARYNGOPHARYNGEAL REFLUX
- Authors: Semenov F.V.1, Gorbonosov I.V.1, Vartanyan MS1, Semenov FV1, Gorbonosov IV1, Vartanyan MS1
-
Affiliations:
- Issue: No 2 (2011)
- Pages: 91-95
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278795
- ID: 278795
Cite item
Full Text
Abstract
About the authors
Fedor Vyacheslavovich Semenov
Igor' Valentinovich Gorbonosov
M S Vartanyan
F V Semenov
I V Gorbonosov
M S Vartanyan
References
- Al Sabbagh G, Wo JM. Supraesophageal manifestations of gastroesophageal reflux disease. Semin Gastrointest Dis 1999;10:113-19.
- Koufman JA, Aviv JE, Casiano RR, at al. Laryngopharyngeal reflux: Position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32-5.
- Bailey BJ, Johnson JT. Head&Neck Surgery-Otolaryngology. Lippincott Williams & Wilkins 2006.
- Toohill RJ, Kuhn JC. Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med 1997;103:100-6.
- Ulualp SO, Toohill RJ. Laryngopharyngeal reflux: state of the art diagnosis and treatment. Otolaryngol Clin North Am 2000;33:785-801.
- Chang JT, Katzka DA. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med 2004;164(14):1482-88.
- Tutuian R, Castell DO. Diagnosis of laryngopharyngeal reflux. Curr Opin Otolaryngol Head Neck Surg 2004;12(3):174-79.
- Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease: a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78.
- Koufman JA, Belafsky PC, Bach KK, et al. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002:112:1606-09.
- Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989;84:12.
- Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111: 1313-17.
- Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease: a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003;1:333-44.
- Steward D, Wilson K, Kelly D, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: A randomized placebo control trial. Otolaryngol Head Neck Surg 2004;13:342-50.
- Westcott CJ, Hopkins MB, Bach KK, et al. Fundoplication for laryngopharyngeal reflux. J Am Coll Surg 2004;199(1):23-30.
- Харкевич Д.А. Фармакология. М., 2006.
- Gupta S. Comparative study of prokinetic drugs. JK Science 2004;6(2):106-108.
- Rudolph CD, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;23:1 [PMID: 11525610].